We previously demonstrated that qualitative analysis using MIBG imaging allows lesion-by-lesion evaluation of the heterogeneity of neuroblastoma response to chemotherapy[None]. In 2 others, the diagnosis of pheochromocytoma was made by biopsy (Table 1). In all patients, the malignant pheochromocytoma was located in non-chromaffin tissue. NoneNoneNoneCharacteristics of patients with malignant pheochromocytoma. However, when FDA is unavailable, DOPA-PET or MIBG scintigraphy can be used as valid alternatives[None]. 